FibroGen Inc (FGEN)
0.304
-0.02
(-5.68%)
USD |
NASDAQ |
Nov 05, 16:00
0.304
0.00 (0.00%)
After-Hours: 18:11
FibroGen Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| December 30, 2022 | 57.22 |
| December 29, 2022 | 56.08 |
| December 28, 2022 | 54.65 |
| December 27, 2022 | 54.40 |
| December 23, 2022 | 55.75 |
| December 22, 2022 | 56.65 |
| December 21, 2022 | 56.25 |
| December 20, 2022 | 51.33 |
| December 19, 2022 | 50.79 |
| December 16, 2022 | 52.36 |
| December 15, 2022 | 51.86 |
| December 14, 2022 | 53.83 |
| December 13, 2022 | 54.15 |
| December 12, 2022 | 51.29 |
| December 09, 2022 | 52.15 |
| December 08, 2022 | 53.75 |
| December 07, 2022 | 55.11 |
| December 06, 2022 | 56.40 |
| December 05, 2022 | 57.83 |
| December 02, 2022 | 58.86 |
| December 01, 2022 | 53.72 |
| November 30, 2022 | 51.33 |
| November 29, 2022 | 50.90 |
| November 28, 2022 | 50.18 |
| November 25, 2022 | 49.47 |
| Date | Value |
|---|---|
| November 23, 2022 | 49.93 |
| November 22, 2022 | 49.22 |
| November 21, 2022 | 49.75 |
| November 18, 2022 | 51.93 |
| November 17, 2022 | 53.50 |
| November 16, 2022 | 53.29 |
| November 15, 2022 | 53.29 |
| November 14, 2022 | 53.40 |
| November 11, 2022 | 55.40 |
| November 10, 2022 | 57.72 |
| November 09, 2022 | 53.97 |
| November 08, 2022 | 50.54 |
| November 07, 2022 | 57.72 |
| November 04, 2022 | 58.04 |
| November 03, 2022 | 58.75 |
| November 02, 2022 | 58.93 |
| November 01, 2022 | 62.26 |
| October 31, 2022 | 58.15 |
| October 28, 2022 | 61.13 |
| October 27, 2022 | 59.78 |
| October 26, 2022 | 63.31 |
| October 25, 2022 | 63.03 |
| October 24, 2022 | 62.35 |
| October 21, 2022 | 58.56 |
| October 20, 2022 | 55.21 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.826
Minimum
Oct 04 2021
63.31
Maximum
Oct 26 2022
11.02
Average
7.158
Median
May 22 2020
Price to Book Value Benchmarks
| Merck & Co Inc | 5.912 |
| Biomarin Pharmaceutical Inc | 2.326 |
| Arbutus Biopharma Corp | 6.097 |
| GlycoMimetics Inc | 1.253 |
| Cidara Therapeutics Inc | 0.7219 |
Price to Book Value Related Metrics
| PS Ratio | 0.1730 |
| Price | 0.304 |
| Earnings Yield | -562.5% |
| Market Cap | 30.52M |